Cyclic 3',5'-AMP phosphodiesterase activity during cyclic AMP-induced differentiation of neuroblastoma cells in culture.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects* / Q000528:radiation effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D051379:Mice; D009447:Neuroblastoma / Q000201:enzymology*; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011453:Prostaglandins / Q000494:pharmacology; D011830:Radiation Effects; D012964:Sodium / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D001593:Benzyl Compounds; D002087:Butyrates; D004987:Ethers; D007093:Imidazoles; D007659:Ketones; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins; D003609:Dactinomycin; D003513:Cycloheximide; D012964:Sodium; D013806:Theophylline; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases